| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.427 | 34.335 | 44.881 | 35.053 | 30.201 | 70.452 | 62.777 | 161.352 | 174.961 |
| Total Income - EUR | - | 19.427 | 34.336 | 44.921 | 35.053 | 30.201 | 70.452 | 70.888 | 161.352 | 174.961 |
| Total Expenses - EUR | - | 5.320 | 13.715 | 8.548 | 6.733 | 6.403 | 8.861 | 8.373 | 14.094 | 40.219 |
| Gross Profit/Loss - EUR | - | 14.108 | 20.621 | 36.373 | 28.320 | 23.798 | 61.590 | 62.516 | 147.257 | 134.742 |
| Net Profit/Loss - EUR | - | 13.525 | 19.545 | 35.026 | 27.269 | 22.939 | 59.519 | 61.189 | 145.886 | 130.281 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Sicare Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 648 | 18.320 | 14.037 | 10.996 | 9.198 | 5.384 | 830 | 396 | 1.505 |
| Current Assets | - | 13.460 | 9.983 | 21.598 | 16.369 | 14.445 | 61.259 | 61.294 | 149.630 | 171.028 |
| Inventories | - | 481 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.396 | 3.038 | 13.119 | 2.161 | 6.439 | 23.915 | 45.141 | 117.242 | 142.502 |
| Cash | - | 11.583 | 6.945 | 8.478 | 14.208 | 8.005 | 37.344 | 16.153 | 32.388 | 28.526 |
| Shareholders Funds | - | 13.570 | 19.598 | 35.078 | 27.319 | 22.989 | 59.567 | 61.282 | 146.013 | 131.259 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 538 | 8.855 | 709 | 241 | 841 | 7.257 | 842 | 4.012 | 41.274 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sicare Med Srl